Perceptive Advisors LLC Portfolio Holdings

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Perceptive Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $3.83 Billion distributed in 108 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $325M, Nuvalent, Inc. with a value of $305M, Amicus Therapeutics, Inc. with a value of $300M, Iovance Biotherapeutics, Inc. with a value of $250M, and Vaxcyte, Inc. with a value of $231M.

Examining the 13F form we can see an increase of $371M in the current position value, from $3.46B to 3.83B.

Perceptive Advisors LLC is based out at New York, NY

Below you can find more details about Perceptive Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.83 Billion
Healthcare: $3.79 Billion
ETFs: $39.5 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 108
  • Current Value $3.83 Billion
  • Prior Value $3.46 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 14 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email